SEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by...

FDA Recall #D-0652-2024 — Class II — August 22, 2024

Recall #D-0652-2024 Date: August 22, 2024 Classification: Class II Status: Ongoing

Product Description

SEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-01

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

ProRx LLC — Exton, PA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

8,396 vials

Distribution

Nationwide in the USA

Code Information

Lot #: ProRx052424, BUD 11/23/2024 ProRx060724, BUD 12/06/2024 ProRx061124, BUD 12/10/2024 ProRx061924, BUD 12/18/2024

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated